Adverse skin reactions associated with hepatitis C treatment: comment.
Lübbe
Jann
J
D000998:Antiviral Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000453:epidemiology*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin